![]() IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. | ![]() AgomAb Therapeutics AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues. | ||
Founding Date | Founding Date 2015 | Founding Date 2014 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Gaithersburg, US HQ | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations Antwerpen, BE HQ Gent, BE |
Employees | Employees 78 | Employees 19 | Employees 62 |
Valuation ($) | Valuation ($) 4.7 b | Valuation ($) 85.3 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($228.9m) (FY, 2025) | Net income ($95.5m) (FY, 2024) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 200m | Total funding raised $ 165.9m | Total funding raised $ 97.6m |

IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
View company
AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues.
View company